BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND MTOR, FRAP2, FRAP1, 2475, ENSG00000198793, P42345, RAPT1, RAFT1, FRAP, FLJ44809 AND Diagnosis
72 results:

  • 1. Metformin and pancreatic neuroendocrine tumors: A systematic review and meta-analysis.
    Cigrovski Berkovic M; Coppola A; Sesa V; Mrzljak A; Lai Q
    World J Gastroenterol; 2024 Feb; 30(7):759-769. PubMed ID: 38515954
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Glutamine synthetase and hepatocellular carcinoma.
    Jiang J; Hu Y; Fang D; Luo J
    Clin Res Hepatol Gastroenterol; 2023 Dec; 47(10):102248. PubMed ID: 37979911
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Case Report: Complete pathological remission of human chorionic gonadotrophin-producing gallbladder carcinoma with multiple liver metastases after treatment with chemotherapy plus an immune checkpoint inhibitor.
    Wang Q; Mu Y; Ji S; Liu Y; Lou Y; Wei S; Dong X; Zhang B
    Front Immunol; 2023; 14():1173520. PubMed ID: 37841278
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Extracellular vesicles long RNA profiling identifies abundant mRNA, circRNA and lncRNA in human bile as potential biomarkers for cancer diagnosis.
    Zong H; Yu W; Lai H; Chen B; Zhang H; Zhao J; Huang S; Li Y
    Carcinogenesis; 2023 Dec; 44(8-9):671-681. PubMed ID: 37696683
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Effects of LAIR-1 on hepatocellular carcinoma cell proliferation and invasion via PI3K-AKT-mtor pathway regulation.
    Zhou T; Liu L; Lan H; Fang D
    Immun Inflamm Dis; 2023 Aug; 11(8):e982. PubMed ID: 37647449
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. High expression of ENPP2 is an independent predictor of poor prognosis in liver cancer.
    Meng J; Ruan X; Wei F; Xue Q
    Medicine (Baltimore); 2023 Aug; 102(31):e34480. PubMed ID: 37543832
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Exploring the molecular pathogenesis, diagnosis and treatment of fibrolamellar hepatocellular carcinoma: A state of art review of the current literature.
    Alshareefy Y; Shen CY; Prekash RJ
    Pathol Res Pract; 2023 Aug; 248():154655. PubMed ID: 37429175
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Primary and secondary angiosarcomas of the liver: a multi-institutional study of 32 cases.
    Liao X; Lai J; Lin J; Zhang D
    Hum Pathol; 2023 Jul; 137():10-17. PubMed ID: 37054784
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. TEA Domain Transcription Factor 1 Inhibits Ferroptosis and Sorafenib Sensitivity of Hepatocellular Carcinoma Cells.
    Li H; Lan H; Zhang M; Zhao F; An N; Yi C
    Dig Dis Sci; 2023 Jul; 68(7):3070-3082. PubMed ID: 36680650
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Exploring the molecular mechanism of hepatitis virus inducing hepatocellular carcinoma by microarray data and immune infiltrates analysis.
    Zhang YZ; Zeb A; Cheng LF
    Front Immunol; 2022; 13():1032819. PubMed ID: 36439183
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The roles and mechanisms of circular RNAs related to mtor in cancers.
    Cao C; Wang Y; Wu X; Li Z; Guo J; Sun W
    J Clin Lab Anal; 2022 Dec; 36(12):e24783. PubMed ID: 36426933
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Differential in vitro effects of targeted therapeutics in primary human liver cancer: importance for combined liver cancer.
    Malik IA; Rajput M; Werner R; Fey D; Salehzadeh N; von Arnim CAF; Wilting J
    BMC Cancer; 2022 Nov; 22(1):1193. PubMed ID: 36402986
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Uterine Leiomyosarcoma Masquerading as a Malignant Perivascular Epithelioid Cell Tumor: A Diagnostic Challenge.
    Natsume T; Yoshida H; Nishikawa T; Kikkawa N; Naka T; Kobayashi-Kato M; Tanase Y; Uno M; Ishikawa M; Kato T
    Int J Surg Pathol; 2023 Aug; 31(5):778-784. PubMed ID: 36310451
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The challenging surgical management of hepatic epithelioid hemangioendothelioma: a narrative review.
    Giovanardi F; Larghi Laureiro Z; Meo GA; Hassan R; Lai Q
    Chin Clin Oncol; 2022 Aug; 11(4):27. PubMed ID: 36098098
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. BAP31 Promotes Proliferation, Invasion, and Metastasis of liver cancer Cells via Activating PI3K/AKT Pathway.
    Sun M; Liu X; Wei W; Ge N; Luo S; Shen S; Ge R
    J Healthc Eng; 2022; 2022():7686728. PubMed ID: 35449837
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Current Status of Malignant Tumors after Organ Transplantation.
    Shen B; Cen Z; Tan M; Song C; Wu X; Wang J; Huang M
    Biomed Res Int; 2022; 2022():5852451. PubMed ID: 35224096
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Rag GTPases suppress PRL-3 degradation and predict poor clinical diagnosis of cancer patients with low PRL-3 mRNA expression.
    Shi Y; Xu S; Ngoi NYL; Hui Y; Ye Z
    Biochem Biophys Res Commun; 2021 Oct; 576():108-116. PubMed ID: 34482023
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Increased expression of Cyclin F in liver cancer predicts poor prognosis: A study based on TCGA database.
    Zelong Y; Han Y; Ting G; Yifei W; Kun H; Haoran H; Yong C
    Medicine (Baltimore); 2021 Aug; 100(31):e26623. PubMed ID: 34397798
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. MiR-92a-3p Promotes the Malignant Progression of Hepatocellular Carcinoma by Mediating the PI3K/AKT/mtor Signaling Pathway.
    Wang L; Cui M; Qu F; Cheng D; Yu J; Tang Z; Cheng L; Wei Y; Wu X; Liu X
    Curr Pharm Des; 2021; 27(29):3244-3250. PubMed ID: 34126886
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Course of renal allograft function after diagnosis and treatment of post-transplant lymphoproliferative disorders in pediatric kidney transplant recipients.
    Zierhut H; Kanzelmeyer N; Buescher A; Höcker B; Mauz-Körholz C; Tönshoff B; Metzler M; Pohl M; Pape L; Maecker-Kolhoff B
    Pediatr Transplant; 2021 Sep; 25(6):e14042. PubMed ID: 34021949
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.